Pitfalls of autoimmune serologic testing Save
Misuse of laboratory testing may lead to misdiagnoses and mismanagement; this is particulary prevalent when clinicians consider the use of the diagnostic use of serological autoimmune markers.
A current review focuses commonly used serologies and autoimmune tests to identify common pitfalls and a diagnostic workflow when suspecting systemic autoimmune diseases.
Practical points from this review:
- Laboratory markers should be used to support a clinical diagnosis, rather than be the sole method of establishing a diagnosis
- The value of a diagnostic test is strongly dependent on the reasons for ordering that test. Value is best with a high probability based on history and examination.
- Mass screening for autoimmune disease or connective tissue disease(s) is not recommended
- Approximately 10–20% of healthy individuals may test positive for ANA depending on the titer [[8], [9], [10]]. It remains unclear whether these individuals will subsequently develop an autoimmune disease.
- ANA positivity appears to have a heritability of roughly 25% (without a future risk of lupus)
- ACPA: Present also before disease onset. Specific for RA; they may be present even when the patient does not meet yet the criteria for RA
- Positive ENA antibodies do not represent always the presence of an autoimmune disease, as these commercially available ENA assays have variable sensitivity and specificity
- ENA testing should not be done in the presence of ANA negativity
- IIF is essential (preferred) to verify the true presence of anti-dsDNA antibodies; ELISA may be more suitable for monitoring dsDNA changes
- ANA and anti-ENA titers tend to remain stable, but anti-dsDNA levels may fluctuate according to disease activity
- anti-thyroid peroxidase and anti-thyroglobulin antibodies are often the sole explanation for ANA positivity (typically with a speckled or homogeneous pattern)
- SPEP: patients presenting with polyclonal gammopathy should be evaluated for chronic infections or autoimmune diseases. The gamma region reflects indeed the immunoglobulin production, including autoantibodies
- C3 & C4 may be low in SLE but also in cryoglobulinemia and hereditary angioedema
More ACR Coverage:
Join The Discussion
In my experience ENA profile may yield positive results in few cases when ANA is negative by IIF. One scanario is low titre anti-Ro antibodies: ENA profile may be more sensative in detection of these. Another scanario is when staining is cytoplasmic and laboratories may not report these e.g. In case of anti- Jo1 antibodies.
NZ - I respectfully disagree. All guidelines say that ordering further serologies with a negative ANA is wrong, costly and more likely to be misleading thant accurate. These ELISA assays are TOOO TOOO sensitive - therein lies their major fault. You cannot claim that as a reason or justifcation. ENA are only useful with ANA+ and only to identify SSA or Sm Abs. All other information is nice but in reality doesnt change dx, treatment or prognosis. If you dont believe me, ask a serology and autoimmune expert that doesnt own a serology laboratory. Best wishes, JC

If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.